BACKGROUND: Physical activity can cause glucose fluctuations both during and after it is performed, leading to hurdles in optimal insulin dosing in people with type 1 diabetes (T1D). We conducted a pilot clinical trial assessing the safety and feasibility of a physical activity-informed mealtime insulin bolus advisor that adjusts the meal bolus according to previous physical activity, based on step count data collected through an off-the-shelf physical activity tracker. METHODS: Fifteen adults with T1D, each using a continuous glucose monitor (CGM) and an insulin pump with carbohydrate counting, completed two randomized crossover daily visits. Participants performed a 30 to 45-minute brisk walk before lunch and lunchtime insulin boluses were calculated based on either their standard therapy (ST) or the physical activity-informed bolus method. Post-lunch glycemic excursions were assessed using CGM readings. RESULTS: There was no significant difference between visits in the time spent in hypoglycemia in the post-lunch period (median [IQR] standard: 0 [0]% vs physical activity-informed: 0 [0]%, P = NS). Standard therapy bolus yielded a higher time spent in 70 to 180 mg/dL target range (mean ± standard: 77% ± 27% vs physical activity-informed: 59% ± 31%, P = .03) yet, it was associated with a steeper negative slope in the early postprandial phase (P = .032). CONCLUSIONS: Use of step count to adjust mealtime insulin following a walking bout has proved to be safe and feasible in a cohort of 15 T1D subjects. Physical activity-informed insulin dosing of meals eaten soon after a walking bout has a potential of mitigating physical activity related glucose reduction in the early postprandial phase.
BACKGROUND: Physical activity can cause glucose fluctuations both during and after it is performed, leading to hurdles in optimal insulin dosing in people with type 1 diabetes (T1D). We conducted a pilot clinical trial assessing the safety and feasibility of a physical activity-informed mealtime insulin bolus advisor that adjusts the meal bolus according to previous physical activity, based on step count data collected through an off-the-shelf physical activity tracker. METHODS: Fifteen adults with T1D, each using a continuous glucose monitor (CGM) and an insulin pump with carbohydrate counting, completed two randomized crossover daily visits. Participants performed a 30 to 45-minute brisk walk before lunch and lunchtime insulin boluses were calculated based on either their standard therapy (ST) or the physical activity-informed bolus method. Post-lunch glycemic excursions were assessed using CGM readings. RESULTS: There was no significant difference between visits in the time spent in hypoglycemia in the post-lunch period (median [IQR] standard: 0 [0]% vs physical activity-informed: 0 [0]%, P = NS). Standard therapy bolus yielded a higher time spent in 70 to 180 mg/dL target range (mean ± standard: 77% ± 27% vs physical activity-informed: 59% ± 31%, P = .03) yet, it was associated with a steeper negative slope in the early postprandial phase (P = .032). CONCLUSIONS: Use of step count to adjust mealtime insulin following a walking bout has proved to be safe and feasible in a cohort of 15 T1D subjects. Physical activity-informed insulin dosing of meals eaten soon after a walking bout has a potential of mitigating physical activity related glucose reduction in the early postprandial phase.
Authors: Meredith C Peddie; Julia L Bone; Nancy J Rehrer; C Murray Skeaff; Andrew R Gray; Tracy L Perry Journal: Am J Clin Nutr Date: 2013-06-26 Impact factor: 7.045
Authors: Sheri R Colberg; Ronald J Sigal; Jane E Yardley; Michael C Riddell; David W Dunstan; Paddy C Dempsey; Edward S Horton; Kristin Castorino; Deborah F Tate Journal: Diabetes Care Date: 2016-11 Impact factor: 19.112
Authors: Mark D DeBoer; Daniel R Cherñavvsky; Katarina Topchyan; Boris P Kovatchev; Gary L Francis; Marc D Breton Journal: Pediatr Diabetes Date: 2016-10-13 Impact factor: 4.866
Authors: Michael C Riddell; Ian W Gallen; Carmel E Smart; Craig E Taplin; Peter Adolfsson; Alistair N Lumb; Aaron Kowalski; Remi Rabasa-Lhoret; Rory J McCrimmon; Carin Hume; Francesca Annan; Paul A Fournier; Claudia Graham; Bruce Bode; Pietro Galassetti; Timothy W Jones; Iñigo San Millán; Tim Heise; Anne L Peters; Andreas Petz; Lori M Laffel Journal: Lancet Diabetes Endocrinol Date: 2017-01-24 Impact factor: 32.069
Authors: Jose Garcia-Tirado; Sue A Brown; Nitchakarn Laichuthai; Patricio Colmegna; Chaitanya L K Koravi; Basak Ozaslan; John P Corbett; Charlotte L Barnett; Michael Pajewski; Mary C Oliveri; Helen Myers; Marc D Breton Journal: Diabetes Technol Ther Date: 2020-12-01 Impact factor: 6.118